-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioids-oa-protocol.pdf
June 29, 2019 - many older adults are
unable to tolerate non-opioid analgesics (e.g., non-steroidal anti-inflammatory drugs … Cyclooxygenase-2
selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction … Do selective cyclo-oxygenase-2
inhibitors and traditional non-steroidal anti-inflammatory drugs increase … A metaanalysis of severe upper
gastrointestinal complications of nonsteroidal antiinflammatory drugs … Meta-analysis of dyspepsia and
nonsteroidal antiinflammatory drugs.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gaps-pain-management.pdf
January 01, 2023 - Some opioids may be less
effective than other drugs. … Key Messages
• Opioids are probably less effective than
nonsteroidal anti-inflammatory drugs (NSAIDs … by the Centers for Disease
Control and Prevention, evaluates the benefits and
harms of nonopioid drugs … Key Messages
As initial therapy in the prehospital setting:
• Nonsteroidal anti-inflammatory drugs … Key Messages
As initial therapy in the prehospital setting:
Nonsteroidal anti-inflammatory drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Coordinating Council for Comparative Effectiveness
Research, AHRQ is interested in innovations in drugs … health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … of tophi and kidney stones.12 Therapy for acute flares consists of nonsteroidal anti-
inflammatory drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1312.pdf
October 01, 2014 - health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … It is also available as the branded drug Ketalar from JHP Pharmaceuticals, LLC, of
Parsippany, NJ. … CNS Drugs. 2012 Mar
1;26(3):189-204. … Rochester (MI): JHP
Pharmaceuticals, LLC; 2011 Jun. 4 p. … Available:
http://www.accessdata.fda.gov/scripts/cder/drugs
atfda/index.cfm?
-
effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual_130826.pdf
August 01, 2013 - health care sector,
horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Questions considered about drugs, biologics, and devices
1. … If so, do not select, because these are “me-too” of existing drugs. … Covers future industry trends,
key industry developments, research and
development of drugs and
pharmaceuticals … Industries covered:
pharmaceuticals, biotechnology, medical
equipment & devices, and in vitro
diagnostics
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-summary.pdf
November 01, 2023 - update for baclofen and 7 new trials for topiramate, and a small
number of studies reported on some drugs … With the help of our technical expert panel, we
limited drugs with off-label uses to those that are … Therefore,
some drugs reviewed as emerging therapies and some only available outside the United
States … In terms of results, our assessment of the effects of those drugs with
Food and Drug Administration
-
effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1406.pdf
June 01, 2014 - Coordinating Council for Comparative Effectiveness
Research, AHRQ is interested in innovations in drugs … health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-appendix-a.pdf
September 26, 2023 - alternative medicine/
12 exp Dietary Supplements/
13 exp Integrative Medicine/
14 Hallucinogenic Drugs … "dialectical behavioural therap*" or Digital or dimethyltryptamine or DMT or doximity or
drug or drugs … OR "dialectical behavioural therap*" OR Digital OR
dimethyltryptamine OR DMT OR doximity OR drug OR drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-evidence-summary.pdf
August 01, 2018 - Some drugs aim to reduce symptoms associated with acute
manic or mixed mania/depression episodes, some … For drugs not approved for BD,
paliperidone also improved acute mania compared to
placebo (low-strength … a number of
observational studies being excluded, including those
that looked at broad classes of drugs … , or individual drugs
across broad populations. … However,
none of the drugs reached MID.
-
effectivehealthcare.ahrq.gov/sites/default/files/s81.pdf
October 01, 2007 - Nurses coded causative drugs
into major classes. … Fewer
classes of drugs commonly cause bleeding. … to these mechanisms are warfa-
rins, heparins, antiplatelet agents, nonsteroidal anti-inflam-
matory drugs … We derived a list of codes reflecting indications where
guidelines17,18 dictate the use of drugs that … Development of models was greatly facilitated by focusing
on the group estimated to be exposed to drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
June 01, 2015 - health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … Nonsteroidal anti-inflammatory drugs (NSAIDs) are used for first-line therapy to
treat AS pain. … Novartis Pharmaceuticals. 16 week efficacy
and 2 year long term safety and efficacy of
secukinumab … Novartis Pharmaceuticals. 16 week efficacy
and 5 year long term efficacy, safety and
tolerability
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonopioid-pharm-chronic-pain-protocol.pdf
February 01, 2019 - most common forms of pharmacologic treatment for pain include opioids, nonsteroidal anti-
inflammatory drugs … (NSAIDs), acetaminophen, topical formulations of drugs such as lidocaine,
and other drugs such as antiseizure … Interventions:
• Oral pharmacologic agents: nonsteroidal anti-inflammatory drugs, acetaminophen,
muscle … , triptans)
• Salicylates (topical and oral)
• Topical menthol preparations
• Disease-modifying drugs … Supplemental Evidence And Data for Systematic review (SEADS): Manufacturers of included
drugs will be
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
April 01, 2012 - Available
therapies for RA include corticosteroids,
oral disease-modifying antirheumatic
drugs or … leflunomide, methotrexate [MTX], and
sulfasalazine), and biologic DMARDs
(five anti-tumor necrosis factor drugs … Finally, very little
is known about the benefits or risks of these drugs in
different patient subgroups … Oral DMARDs
Anti-tumor necrosis factor
drugs vs. … Information is also needed about the performance of these
drugs in subgroups of patients defined by
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol.pdf
September 13, 2024 - For example, emergency department visits related to
NMU of these drugs by adults increased from 5,212 … Misuse of Prescription Drugs Research Report. 2023. … https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/overview. … MMWR
https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/overview
https://
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1512.pdf
December 01, 2015 - health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … Safety of antiobesity drugs. Ther Adv Drug Saf.
2013;4(4):171-81. … Anti-
obesity drugs: Past, present and future. Dis
Model Mech. 2012 Sep;5(5):621-6.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/headaches-pregnancy.pdf
March 23, 2019 - For example, nonsteroidal anti-
inflammatory drugs (NSAIDs) have been shown to be associated with a higher … therapies used outside of pregnancy, such as complementary and alternative therapies and
biologic drugs … Use of non-steroidal anti-inflammatory drugs
in pregnancy: impact on the fetus and newborn. … https://www.fda.gov/drugs/drugsafety/ucm350684.htm. Accessed on March 23, 2019. … https://www.fda.gov/drugs/drugsafety/ucm350684.htm
19
16. Andrade C.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/research-protocol-osteoporosis_2.pdf
October 05, 2018 - Drugs Used for Osteoporosis Treatment and Prevention
Drug class Drug name Delivery
route
Dosing … Interventions • Drugs FDA approved for osteoporosis treatment or prevention (bisphosphonates, denosumab
-
effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_june_2012.pdf
January 01, 2012 - Coordinating Council for Comparative Effectiveness
Research, AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … below lists the three topics for which (1) preliminary phase III or later data were
available for drugs … The experts stated oral
treprostinil could be used more frequently than other drugs to treat patients
-
effectivehealthcare.ahrq.gov/sites/default/files/depression_hi_impact.pdf
October 01, 2014 - health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … interventions expected to be within 0 to 4 years of potential diffusion (e.g., in phase III trials
for pharmaceuticals … study for use
in the treatment of bipolar depression.
25
The drug was originally launched by King Pharmaceuticals … Drugs Future
2009;34(3):217-21.
25. Thomson Reuters Integrity [database online]. … J Psychoactive
Drugs 2008 Sep;40(3):225-36. PMID:
19004414
54.
-
effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
January 01, 2012 - In the health care sector, horizon
scanning pertains to identifying new (and new uses of existing) pharmaceuticals … These therapies are extended-release exenatide for injection
(Bydureon
™
, Amylin Pharmaceuticals, … exenatide (exenatide once-weekly [EQW]; Bydureon
™
, Eli Lilly and Co.,
Indianapolis, IN, Amylin Pharmaceuticals … San Diego (CA): Amylin
Pharmaceuticals, Inc.; 2012 Jan 27 [accessed
2012 Feb 20]. [4 p]. … San
Diego (CA): Amylin Pharmaceuticals, Inc.; 2012
Jan 27. 11 p.